140 related articles for article (PubMed ID: 29652202)
1. Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests.
Nunokawa T; Yokogawa N; Shimada K; Sugii S
Mod Rheumatol; 2019 May; 29(3):436-440. PubMed ID: 29652202
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study.
Nunokawa T; Yokogawa N; Shimada K; Sugii S; Nishino J; Gosho M; Wagatsuma Y; Tohma S
Semin Arthritis Rheum; 2019 Feb; 48(4):573-578. PubMed ID: 30057321
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
Nunokawa T; Chinen N; Shimada K; Kimura M; Tateishi M; Chen FY; Setoguchi K; Sugihara M
J Infect Chemother; 2023 Feb; 29(2):193-197. PubMed ID: 36334836
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
6. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
[TBL] [Abstract][Full Text] [Related]
7. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
Rice ML; Barreto JN; Thompson CA; Mara KC; Tosh PK; Limper AH
Cancer Med; 2021 Aug; 10(15):5120-5130. PubMed ID: 34155819
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer.
Lee EH; Kim EY; Lee SH; Roh YH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
Sci Rep; 2019 Feb; 9(1):2094. PubMed ID: 30765832
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
14. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study.
Tadros S; Teichtahl AJ; Ciciriello S; Wicks IP
Semin Arthritis Rheum; 2017 Jun; 46(6):804-809. PubMed ID: 27814896
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature.
Gupta D; Zachariah A; Roppelt H; Patel AM; Gruber BL
J Clin Rheumatol; 2008 Oct; 14(5):267-72. PubMed ID: 18679133
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
Schipper LG; Fransen J; Barrera P; Van Riel PL
Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
[TBL] [Abstract][Full Text] [Related]
19. Fatal Pneumocystis jirovecii pneumonia in a HIV-negative adult.
Haddad TM; Vallabhajosyula S; Nawaz MS; Vivekanandan R
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26311008
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jirovecii pneumonia in African miners at autopsy.
Wong ML; Back P; Candy G; Nelson G; Murray J
Int J Tuberc Lung Dis; 2006 Jul; 10(7):756-60. PubMed ID: 16848337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
